Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
FabRx Ltd.
Ashford, Reino UnidoPublicacións en colaboración con investigadores/as de FabRx Ltd. (9)
2024
-
3D Printing of Dietary Products for the Management of Inborn Errors of Intermediary Metabolism in Pediatric Populations
Nutrients, Vol. 16, Núm. 1
-
Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders
International Journal of Pharmaceutics, Vol. 657
2023
-
Inkjet drug printing onto contact lenses: Deposition optimisation and non-invasive dose verification
International Journal of Pharmaceutics: X, Vol. 5
2021
-
3D printed tacrolimus suppositories for the treatment of ulcerative colitis
Asian Journal of Pharmaceutical Sciences, Vol. 16, Núm. 1, pp. 110-119
-
3D printing of pharmaceutical products
Additive Manufacturing (Elsevier), pp. 569-597
2020
-
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
-
Gastrointestinal tracking and gastric emptying of coated capsules in rats with or without sedation using CT imaging
Pharmaceutics, Vol. 12, Núm. 1
2019
-
Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients
International Journal of Pharmaceutics, Vol. 567
2018
-
PET/CT imaging of 3D printed devices in the gastrointestinal tract of rodents
International Journal of Pharmaceutics, Vol. 536, Núm. 1, pp. 158-164